![[ICO]](/icons/blank.gif){kind=icon}
![[DIR]](/icons/back.gif){kind=icon}
![[ ]](/icons/layout.gif){kind=icon}
| Name | Last modified | Size | Description |
|---|---|---|---|---|
| Parent Directory | - | ||
| 1 Economic.pdf | 29-Aug-2014 05:37 | 3.4M | |
| 2 Bevacizumab.pdf | 29-Aug-2014 05:37 | 5.1M | |
| 3 Prevalence.pdf | 29-Aug-2014 05:37 | 366K | |
| 4 Primary.pdf | 29-Aug-2014 05:37 | 315K | |
| 5 2539-2546.pdf | 29-Aug-2014 05:37 | 1.3M | |
| 6 Combined.pdf | 29-Aug-2014 05:37 | 4.2M | |
| 7 Bleb-Limiting.pdf | 29-Aug-2014 05:37 | 561K | |
| 8 Insertion.pdf | 29-Aug-2014 05:37 | 747K | |
| 9 uveal.pdf | 29-Aug-2014 05:37 | 2.4M | |
| 10Paraneoplastic.pdf | 29-Aug-2014 05:37 | 407K | |
| 11 Botulinum Toxin.pdf | 29-Aug-2014 05:37 | 1.6M | |
| 12 Anti.pdf | 29-Aug-2014 05:37 | 1.1M | |
| 13 Bannatikan.pdf | 29-Aug-2014 05:37 | 108K | |
| 14 Thaybut fig color.pdf | 29-Aug-2014 05:37 | 22M | |
| Pok Jaksu 20 1.pdf | 29-Aug-2014 05:37 | 132K | |
| Saruban 20 1.pdf | 29-Aug-2014 05:37 | 164K | |
| long pok 20 1.pdf | 29-Aug-2014 05:37 | 141K | |